Publisher Correction: Personalized early detection and prevention of breast cancer: ENVISION consensus statement
| Autor: | Harry J. de Koning, Paul D.P. Pharoah, Suzette Delaloge, Camille Baron, Jelle Wesseling, Marc Tischkowitz, Douglas F. Easton, Sandrine De Montgolfier, Mireille J. M. Broeders, Marjanka K. Schmidt, Peter Devilee, Montserrat Garcia-Closas, Laura J. Esserman, Per Hall, Martin Widschwendter, Daniel Reisel, Zdenko Herceg, Paolo Giorgi Rossi, Rita K. Schmutzler, Urška Ivanuš, Andres Metspalu, Corinne Balleyguier, Jacques Simard, Sowmiya Moorthie, Nora Pashayan, David Ritchie, Odette Wegwarth, Jack Cuzick, Antonis C. Antoniou, Thomas Callender, D. Gareth Evans, David P. French, Gaby Sroczynski, Clare Turnbull |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty Consensus Statement (logic) Oncology and Carcinogenesis MEDLINE Early detection Breast Neoplasms 03 medical and health sciences 0302 clinical medicine Breast cancer Humans Mass Screening Medicine Genetic Predisposition to Disease Medical physics Precision Medicine Early Detection of Cancer Cancer Evidence-Based Medicine business.industry Published Erratum medicine.disease Publisher Correction 030104 developmental biology Good Health and Well Being Oncology 030220 oncology & carcinogenesis Female business |
| Zdroj: | Nature reviews. Clinical oncology, vol 17, iss 11 Nature Reviews Clinical Oncology Nat Rev Clin Oncol |
| Popis: | The European Collaborative on Personalized Early Detection and Prevention of Breast Cancer (ENVISION) brings together several international research consortia working on different aspects of the personalized early detection and prevention of breast cancer. In a consensus conference held in 2019, the members of this network identified research areas requiring development to enable evidence-based personalized interventions that might improve the benefits and reduce the harms of existing breast cancer screening and prevention programmes. The priority areas identified were: 1) breast cancer subtype-specific risk assessment tools applicable to women of all ancestries; 2) intermediate surrogate markers of response to preventive measures; 3) novel non-surgical preventive measures to reduce the incidence of breast cancer of poor prognosis; and 4) hybrid effectiveness-implementation research combined with modelling studies to evaluate the long-term population outcomes of risk-based early detection strategies. The implementation of such programmes would require health-care systems to be open to learning and adapting, the engagement of a diverse range of stakeholders and tailoring to societal norms and values, while also addressing the ethical and legal issues. In this Consensus Statement, we discuss the current state of breast cancer risk prediction, risk-stratified prevention and early detection strategies, and their implementation. Throughout, we highlight priorities for advancing each of these areas. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|